164 related articles for article (PubMed ID: 37709553)
21. Systemic lupus erythematosus in the light of the COVID-19 pandemic: infection, vaccination, and impact on disease management.
Mehta P; Gasparyan AY; Zimba O; Kitas GD
Clin Rheumatol; 2022 Sep; 41(9):2893-2910. PubMed ID: 35639259
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis A virus vaccination in childhood-onset systemic lupus erythematosus.
Mertoglu S; Sahin S; Beser OF; Adrovic A; Barut K; Yuksel P; Sazak S; Kocazeybek BS; Kasapcopur O
Lupus; 2019 Feb; 28(2):234-240. PubMed ID: 30551721
[TBL] [Abstract][Full Text] [Related]
23. Safety of vaccination of patients with systemic lupus erythematosus.
Abu-Shakra M
Lupus; 2009 Nov; 18(13):1205-8. PubMed ID: 19880569
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccination questionnaire in patients with systemic lupus erythematosus: an observational study.
Cheng RJ; Li YH; Liu ZH; Zhou A; Li Z; Ma L; Liu Y
Lupus Sci Med; 2023 Jul; 10(2):. PubMed ID: 37433740
[No Abstract] [Full Text] [Related]
25. New-onset systemic lupus erythematosus after ChAdOX1 nCoV-19 and alopecia areata after BNT162b2 vaccination against SARS-CoV-2.
Gamonal SBL; Marques NCV; Pereira HMB; Gamonal ACC
Dermatol Ther; 2022 Sep; 35(9):e15677. PubMed ID: 35770484
[No Abstract] [Full Text] [Related]
26. Patients with systemic lupus erythematosus and their experience with vaccination against COVID-19: a descriptive and explanatory study.
Ceccarelli F; Covelli V; Olivieri G; Natalucci F; Alessandri C; Conti F
Reumatismo; 2022 Sep; 74(2):. PubMed ID: 36101990
[TBL] [Abstract][Full Text] [Related]
27. Systemic lupus erythematosus with acrocyanosis after AstraZeneca COVID-19 vaccination.
Wang HJ; Sun Y; Lan CE
Kaohsiung J Med Sci; 2022 Dec; 38(12):1230-1231. PubMed ID: 36448713
[No Abstract] [Full Text] [Related]
28. Induction and exacerbation of subacute cutaneous lupus erythematosus following mRNA-based or adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Licciardi-Fernandez MJ; Burmann SN; Burkert B; Oellig F; Michalowitz AL
Clin Exp Dermatol; 2022 Jan; 47(1):161-163. PubMed ID: 34291477
[TBL] [Abstract][Full Text] [Related]
29. Attitudes towards and safety of the SARS-CoV-2 inactivated vaccines in 188 patients with systemic lupus erythematosus: a post-vaccination cross-sectional survey.
Tang Q; Li F; Tian J; Kang J; He J
Clin Exp Med; 2023 Jun; 23(2):457-463. PubMed ID: 35612692
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous lupus-erythematosus-like reaction arising after COVID-19 vaccination.
Rose C; Apgar R; Green M
J Cutan Pathol; 2022 Nov; 49(11):943-946. PubMed ID: 35754159
[TBL] [Abstract][Full Text] [Related]
31. Immune responses and disease biomarker long-term changes following COVID-19 mRNA vaccination in a cohort of rheumatic disease patients.
An Z; Figueroa-Parra G; Zhou X; Li Y; Jaquith J; McCarthy-Fruin K; Sletten J; Warrington KJ; Weyand C; Crowson CS; Chumsri S; Knutson KL; Sanchez-Rodriguez A; Thanarajasingam U; Duarte-García A; Zeng H
Front Immunol; 2023; 14():1224702. PubMed ID: 37583697
[TBL] [Abstract][Full Text] [Related]
32. Transition of cutaneous into systemic lupus erythematosus following adenoviral vector-based SARS-CoV-2 vaccination.
Kreuter A; Burmann SN; Burkert B; Oellig F; Michalowitz AL
J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):e733-e735. PubMed ID: 34243220
[No Abstract] [Full Text] [Related]
33. Subacute cutaneous lupus erythematosus triggered after measles vaccination.
de Mattos ABN; Garbo Baroni L; Zanotto LL; Furian MEA
Lupus; 2021 Apr; 30(5):833-835. PubMed ID: 33573457
[TBL] [Abstract][Full Text] [Related]
34. Systemic lupus erythematosus with acute pancreatitis and vasculitic rash following COVID-19 vaccine: a case report and literature review.
N AM; Saleh AM; Khalid A; Alshaya AK; Alanazi SMM
Clin Rheumatol; 2022 May; 41(5):1577-1582. PubMed ID: 35175446
[TBL] [Abstract][Full Text] [Related]
35. The case for Zostavax vaccination in systemic lupus erythematosus.
Cogman AR; Chakravarty EF
Vaccine; 2013 Aug; 31(36):3640-3. PubMed ID: 23742992
[No Abstract] [Full Text] [Related]
36. Impact of BNT162b2 mRNA anti-SARS-CoV-2 vaccine on interferon-alpha production by plasmacytoid dendritic cells and autoreactive T cells in patients with systemic lupus erythematosus: The COVALUS project.
Mageau A; Tchen J; Ferré VM; Nicaise-Roland P; Descamps D; Delory N; François C; Mendes C; Papo T; Goulenok T; Charles N; Sacré K
J Autoimmun; 2023 Jan; 134():102987. PubMed ID: 36563528
[TBL] [Abstract][Full Text] [Related]
37. Exacerbation of subacute cutaneous lupus erythematosus following vaccination with BNT162b2 mRNA vaccine.
Niebel D; Ralser-Isselstein V; Jaschke K; Braegelmann C; Bieber T; Wenzel J
Dermatol Ther; 2021 Jul; 34(4):e15017. PubMed ID: 34075664
[No Abstract] [Full Text] [Related]
38. Autoimmunity-related neutrophilic dermatosis after coronavirus disease 2019 vaccination: A case report and literature review.
Kishibe M; Koike K; Kanno K; Ishida-Yamamoto A
J Dermatol; 2023 Jun; 50(6):820-823. PubMed ID: 36606292
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus, immunosuppressives, COVID-19 vaccination, and antibody response: comment on the article by Petri et al.
Kleebayoon A; Wiwanitkit V
Arthritis Care Res (Hoboken); 2023 Oct; 75(10):2224-2225. PubMed ID: 36861888
[No Abstract] [Full Text] [Related]
40. Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus.
Zavala-Flores E; Salcedo-Matienzo J; Quiroz-Alva A; Berrocal-Kasay A
Clin Rheumatol; 2022 May; 41(5):1349-1357. PubMed ID: 34782941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
